Appleton Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-2,790
| Closed | -$233K | – | 292 |
|
|
2021
Q2 | $233K | Sell |
2,790
-635
| -19% | -$53K | 0.02% | 275 |
|
|
2021
Q1 | $259K | Sell |
3,425
-1,269
| -27% | -$96K | 0.02% | 256 |
|
|
2020
Q4 | $412K | Sell |
4,694
-2,485
| -35% | -$218K | 0.04% | 205 |
|
|
2020
Q3 | $546K | Sell |
7,179
-530
| -7% | -$40.3K | 0.06% | 176 |
|
|
2020
Q2 | $951K | Buy |
7,709
+966
| +14% | +$119K | 0.11% | 137 |
|
|
2020
Q1 | $570K | Buy |
6,743
+603
| +10% | +$51K | 0.08% | 157 |
|
|
2019
Q4 | $519K | Buy |
6,140
+515
| +9% | +$43.5K | 0.06% | 190 |
|
|
2019
Q3 | $379K | Sell |
5,625
-785
| -12% | -$52.9K | 0.05% | 216 |
|
|
2019
Q2 | $549K | Buy |
6,410
+21
| +0.3% | +$1.8K | 0.07% | 181 |
|
|
2019
Q1 | $568K | Buy |
6,389
+1,348
| +27% | +$120K | 0.08% | 173 |
|
|
2018
Q4 | $429K | Sell |
5,041
-405
| -7% | -$34.5K | 0.06% | 187 |
|
|
2018
Q3 | $528K | Buy |
5,446
+1,096
| +25% | +$106K | 0.07% | 182 |
|
|
2018
Q2 | $410K | Buy |
+4,350
| New | +$410K | 0.06% | 199 |
|